Bausch Health
BHC
#4798
Rank
NZ$3.49 B
Marketcap
NZ$9.35
Share price
0.37%
Change (1 day)
24.47%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): NZ-$5.67

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.54. In 2025 the company made an earnings per share (EPS) of NZ$0.72 an increase over its 2024 EPS that were of NZ-$0.21.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.67-889.9%
2025NZ$0.72-450%
2024NZ-$0.21-92.59%
2023NZ-$2.77160.89%
2022NZ-$1.06-76.64%
2021NZ-$4.5468.45%
2020NZ-$2.70-68.91%
2019NZ-$8.67-57.11%
2018NZ-$20.22-272.22%
2017NZ$11.74-199.29%
2016NZ-$11.83798.7%
2015NZ-$1.32-128.31%
2014NZ$4.65-204.62%
2013NZ-$4.44602.7%
2012NZ-$0.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.41-92.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.62-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA